Bio-Rad Laboratories, Inc. (BIO) NYSE

301.75

+0.72(+0.24%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap9.27B
Enterprise Value10.16B
P/E Ratio-12.02
PEG Ratio0.04
Price/Sales Ratio3.18
Price/Book Ratio1.21
Enterprise/Revenue3.57
Enterprise/EBITDA-14.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.26
Operating Margin0.09

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.1

Income Statement

Revenue2.57B
Revenue/Share94.99
Gross Profit1.38B
EBITDA-2.14B
Net Income-1.84B
Diluted EPS-65.36

Balance Sheet

Total Cash1.42B
Total Cash/Share52.77
Total Debt1.4B
Total Debt/Equity0.21
Current Ratio5.44
Book Value Per Share250.22

Price History

52-Week Change-8.94
52-Week High373.69
52-Week Low211.43
Moving Average 50 Days314.84
Moving Average 200 Days271.72

Statistics

Average Volume204,642
Shares Outstanding26.97M
% Held by Institutions71.51

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.09
Last Split Factor2:1
Last Split DateMarch 08, 2002